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ABSTRACT: Water-soluble metalla-cages were used to 
deliver hydrophobic porphin molecules to cancer cells. 
After internalization, the photosensitizer was photo-
activated, significantly increasing the cytotoxicity in cells. 
During the transport, the photosensitizer remains non-
reactive to light, offering a new strategy to tackle overall 
photosensitization, a limitation often encountered in 
photodynamic therapy.
I n recent years, the use of large vehicles to carryphotosensitizers to cancer cells has attracted much interest.1
Photosensitizers such as porphyrins and phthalocyanines are in
general poorly water-soluble, unless highly substituted with
hydrophilic groups.2 Therefore, encapsulation of the photo-
sensitizer within the hydrophobic cavity of water-soluble
carriers provides an elegant strategy to transport photo-
sensitizers in aqueous media, a necessity for biological
applications. Moreover, most photosensitizers show poor
selectivity to diseased cells and consequently generate an
overall photosensitization of the entire body. Thus, spatial-
controlled release of the photosensitizer remains one of the
main challenges in photodynamic therapy.3
Recently, water-soluble arene ruthenium metalla-cages
have been used to deliver hydrophobic molecules to cancer
cells.4 In an extension to this work, we have now encapsulated
porphin, a well-known lipophilic photosensitizer,5 in two catio-
nic arene ruthenium metalla-cages (Figure 1). In the hexa-
nuclear metalla-prism, [Ru6(η
6-p-PriC6H4Me)6(tpt)2(dobq)3]
6+
([1]6+; tpt = 2,4,6-tris(4-pyridyl)-1,3,5-triazine; dobq =
2,5-dioxido-1,4-benzoquinonato), porphin is trapped in the
cavity of [1]6+, while in the larger octanuclear metalla-cube
[Ru8(η
6-p-PriC6H4Me)8(tpvb)2(donq)4]
8+ ([2]8+; tpvb =
1,2,4,5-tetrakis{2-(4-pyridyl)vinyl}benzene; donq = 5,8-dioxi-
do-1,4-naphthoquinonato), porphin is reversibly encapsulated
and can be released without rupture of the cage compound.
The antiproliferative activity and the phototoxicity of the empty
cages and the porphin⊂cage systems have been evaluated on
human cancer cell lines from different phenotypes. Moreover,
stability of the cages, uptake of the host−guest systems, and
release of porphin after internalization in the cells have been
studied by fluorescence spectroscopy.
Synthesis of the empty metalla-prism [1]6+ has been reported
previously.4 However, synthesis of the carceplex [porphin⊂1]6+
is new and requires the addition of porphin during the
formation of [1]6+ (see Supporting Information (SI)). The
encapsulation of porphin in [1]6+ is easily monitored by 1H
NMR spectroscopy (Figure 2). Indeed, the signals associated
with the protons of the porphin molecule are shifted upfield
due to the encapsulation. Moreover, diffusion-ordered NMR
spectroscopy (DOSY)6 clearly demonstrates that the porphin
molecule is trapped in the hydrophobic cavity of [1]6+, as
illustrated in Figure 2. The carceplex [porphin⊂1]6+ is isolated
as the triflate salt.
Synthesis of the metalla-cube [2]8+ follows the same strategy
using 4 equiv of [Ru2(η
6-p-PriC6H4Me)2(donq)Cl2]
7 and 2
equiv of tpvb8 in methanol at reflux for 24 h (SI). Likewise,
[porphin⊂2][CF3SO3]8 is prepared by adding 1 equiv of
porphin during the formation of [2]8+. The empty cage and the
host−guest system have been fully characterized by 1H, 13C,
and DOSY NMR spectroscopy, as well as by ESI-MS and
elemental analysis. The encapsulation of porphin in the cavity
of [2]8+ was confirmed by DOSY measurements (Figure 2). As
compared to [porphin⊂1]6+, the proton signals of the
encapsulated porphin molecule in [2]8+ are broad with a
similar upfield shift, but as expected for a porphin⊂cage system
they are all diffusing with the proton signals of the cage. The
broadness of the signals is due to the large cavity size of [2]8+,
in which porphin is free to move. Indeed, Chem3D models of
both9 [porphin⊂1]6+ and [porphin⊂2]8+ systems give clear
pictures of the porphin environment in the cavities of [1]6+ and
[2]8+ (Figure 3).
Spectroscopic measurements were realized on porphin, the
empty cages as well as the porphin⊂cage systems. UV−visFigure 1. Molecular structures of [porphin⊂1]6+ and [porphin⊂2]8+.
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absorption spectra reveal hypochromism of the characteristic
porphin bands when trapped inside both cages (Figure S1),
while the porphin fluorescence intensity almost vanishes upon
encapsulation (see Figure 4). The strong hypochromism of the
fluorescence is a useful phenomenon to study the uptake and
stability of the systems as well as to follow the release of the
guest by the cage compounds after internalization by the cells.10
In addition, the ability of porphin, the empty cages, and the
porphin⊂cage compounds to generate reactive oxygen species
has been evaluated. All complexes [1][CF3SO3]6, [2]-
[CF3SO3]8, [porphin⊂1][CF3SO3]6, and [porphin⊂2]-
[CF3SO3]8 show no production of singlet oxygen in ethanol/
DMSO as opposed to porphin, which possesses after excitation
at 414 nm a singlet oxygen quantum yield of 97% (Table S1).
Consequently, empty and porphin⊂cage systems can be
considered harmless in term of phototoxicity; only after release
of porphin is photoactivity regained.
The stability of the porphin⊂cage systems has been evaluated
under various biological conditions (see SI). All complexes are
stable at physiological pH from 6 to 8 at 37 °C. In the presence
of oxidative (H2O2) or reductive (dithiothreitol) derivatives, no
degradation of the host−guest systems is observed. Similarly,
when exposed to complete culture medium, the porphin⊂cage
systems remain intact.
The uptake and release of porphin after internalization of the
host−guest systems have been studied for various human
cancer cells, Me300, A2780, A2780cisR, HeLa, and A549
(Table 1). The antiproliferative activity of the complexes in the
dark was evaluated, demonstrating that the empty cages and
porphin⊂cage systems present moderate cytotoxicities with
comparable values in the cell lines tested. All IC50 values are
comprised in the range 5−12 μM (Table 1), and no significant
differences were found between the empty and porphin⊂cage
systems. Moreover, despite the presence of eight ruthenium
atoms per metalla-cage in [2]8+, as opposed to only six in [1]6+,
[porphin⊂2]8+ is slightly less cytotoxic than [porphin⊂1]6+.
Interestingly, the porphin fluorescence could be detected
intracellularly during the incubation of cells with the porphin⊂-
cage systems. A stronger signal for [porphin⊂2]8+ than
[porphin⊂1]6+ in all cell lines was observed, suggesting a
higher porphin release inside the cells (Figure 5). The
differences in fluorescence after 72 h incubation can be
correlated to the nature of the porphin⊂cage systems. Indeed,
as emphasized in Figure 3, the release of porphin requires two
different mechanisms depending on the cages: rupture of the
cage in [porphin⊂1]6+, while in [porphin⊂2]8+ the porphin
molecule can diffuse through an aperture without breakage of
the cage.
The uptake of the porphin⊂cage systems by cells was further
visualized by fluorescence microscopy. Cells incubated with
Figure 2. 1H NMR (CD2Cl2, 23 °C) and DOSY spectra of porphin,
[porphin⊂1][CF3SO3]6, and [porphin⊂2][CF3SO3]8.
Figure 3. Chem3D models of the metalla-cages [porphin⊂1]6+ and
[porphin⊂2]8+: side and top views.
Figure 4. Fluorescence spectra of porphin and porphin⊂cage systems
(isopropanol/dmso, 10−4 M, excitation 405 nm).
Table 1. Cytotoxicity of Porphin⊂Cage Systems for Various
Human Cancer Cells after 72 h Incubation in the Dark
IC50 (μM)
cells [porphin⊂1]6+ [porphin⊂2]8+
Me300 5.7 ± 0.9 5.0 ± 0.1
A2780 6.0 ± 0.8 12.0 ± 0.5
A2780cisR 5.2 ± 0.9 6.2 ± 1.7
HeLa 9.5 ± 1.3 12.5 ± 3.1
A549 8.5 ± 1.7 11.2 ± 5.0
2
[porphin⊂1]6+ did not present enough fluorescence to be
detected, while incubation with [porphin⊂2]8+ revealed strong
red and blue fluorescence spots corresponding to porphin
molecules and empty cages, respectively (Figure 6). These
findings confirm the intracellular release of porphin from the
cage and also indicate that both the cage and porphin are located
in different compartments of the cell and not in the nucleus.
The photodynamic efficiency of both porphin⊂cage systems
was evaluated in HeLa cells at 0.5 μM concentration (∼20
times below the IC50 concentration, 20 h incubation). Excellent
phototoxicities were found for both cages, confirming the
release of porphin from the cage (Figure 7). Moreover,
[porphin⊂2]8+ (0.2 J/cm2) was 10 times more photoactive
than [porphin⊂1]6+ (2.1 J/cm2). This result is in complete
agreement with intracellular measurements of porphin
fluorescence and singlet oxygen quantum yield, linking the
release of porphin with photoefficiency.
In conclusion, we have demonstrated that the metalla-cages
were able to carry and deliver intracellularly photosensitizers
following uptake by cells. The release of porphin is higher for
the larger cubic cage as compared to the smaller prismatic cage.
These systems display hypochromism properties toward the
photosensitizer loaded inside the cavity of the cage, resulting in
the absence of phototoxic effect outside of cells. This ability
defines our cages as very safe and powerful tools for new
photodynamic strategies that may not induce overall photo-
sensitization in patients and therefore allow better efficiency in
photodynamic treatment.
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